UAB researchers report Phase 1 trial results showing a novel immunotherapy safely doubled the time glioblastoma patients ...

Tiny silica nanoparticles engineered to seek out prostate cancer caused tumor cells to self-destruct and supercharged the ...

Patients with triple-negative breast cancer who cannot receive immunotherapy now have a new first-line treatment option after ...

Researchers from The University of Texas MD Anderson Cancer Center demonstrated that an artificial intelligence (AI)-based ...

Creatine is one of the most popular fitness supplements in the world. It is widely used by athletes, bodybuilders, and ...

Results from a phase 3 clinical trial published in the New England Journal of Medicine, today (June 2nd) show that patients with lung cancer who received an immunotherapy drug, nivolumab, along with ...

Scientists have discovered that creatine may strengthen one of the immune system's most important cancer-fighting pathways by energizing dendritic cells that activate killer T cells. The promising ...

Jenney Bitner feared she wouldn't get to see her children grow up after a tumor in her brain revealed she had Stage IV ...

DUBLIN--(BUSINESS WIRE)--The "Oncolytic Virus Immunotherapy - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Oncolytic Virus Immunotherapy ...

In a notice flagging a series of problems with a clinical trial, the journal Nature Medicine said its editors “no longer have confidence in the integrity of the results.” ...

A Toronto-based team is launching a massive, years-long research project to study liquid biopsies, a novel technology meant ...

Glioblastoma, the most aggressive malignant brain tumor in adults, remains one of the most challenging cancers to treat ...